HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Anzhou Xia Selected Research
Anzhou Xia Research Topics
Disease
5
Fibrosis (Cirrhosis)
11/2020 - 01/2015
4
Ischemia
01/2021 - 01/2014
4
Ureteral Obstruction
11/2020 - 01/2015
3
Reperfusion Injury
07/2014 - 01/2014
2
Myocardial Ischemia (Ischemic Heart Diseases)
02/2014 - 01/2014
1
Diabetic Nephropathies (Diabetic Nephropathy)
11/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018
Drug/Important Bio-Agent (IBA)
3
salicylhydroxamic acid (SHAM)
IBA
01/2015 - 01/2014
2
Febuxostat
FDA Link
03/2019 - 01/2015
2
Proteins (Proteins, Gene)
FDA Link
10/2018 - 07/2014
2
Bone Morphogenetic Protein 7
IBA
04/2016 - 01/2015
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
01/2021
1
anisodamine
IBA
01/2021
1
Metformin (Glucophage)
FDA Link
Generic
11/2020
1
Xanthine Oxidase
IBA
03/2019
1
TOR Serine-Threonine Kinases
IBA
10/2018
1
Cisplatin (Platino)
FDA Link
Generic
10/2018
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
10/2018
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
12/2017
1
Cytokines
IBA
12/2017
1
Artesunate
IBA
04/2016
1
HSP27 Heat-Shock Proteins
IBA
07/2014
1
Mitogen-Activated Protein Kinases
IBA
07/2014
1
MAP-kinase-activated kinase 2
IBA
07/2014
1
SB 203580
IBA
07/2014
1
Naloxone (Narcan)
FDA Link
Generic
02/2014
1
JNK Mitogen-Activated Protein Kinases
IBA
02/2014
1
Betulinic Acid
IBA
01/2014
1
Fosinopril (Monopril)
FDA Link
Generic
01/2014
Therapy/Procedure
1
Therapeutics
10/2018
1
Ischemic Postconditioning
07/2014